OpenVSafe by OpenVAERS
Search V-safe

RM6-56370-17443

4 vaccinations 3 coded responses 11 check-ins 2 free-text entries 1 call case
Sex
Female
Age at first dose
36-40
ZIP prefix
088 / NJ
Registered
2021-04-22
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino
Registered dependents
F9M-24680-15208 Child or adolescent in my care · Female · 2022-06-28

Timeline

  1. 2021-03-29
    Dose 1 — Pfizer-BioNTech
  2. 2021-04-19
    Dose 2 — Pfizer-BioNTech
  3. 2021-04-22
    Registered in v-safe
  4. 2021-04-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-04-23
    Survey response — days 1–6 daily, dose 2
    MedDRA: Breast feeding — Feeling: Good · Site: Pain
    Free text: I am breastfeeding and my breasts have felt particularly full and sometimes I had breast discomfort in the 2-3 days following my 2nd shot.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-04-24
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  7. 2021-04-25
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  8. 2021-04-29
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  9. 2021-05-03
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  10. 2021-07-19
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  11. 2021-10-18
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-11-09
    Dose 3 — Pfizer-BioNTech
  13. 2022-04-19
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in
  14. 2022-09-23
    Dose 4 — Moderna
  15. 2022-12-27
    Survey response — 3 months, dose 4
    MedDRA: Bronchitis, Conjunctivitis, Nasopharyngitis — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Colds, bronchitis, and pink eye
    MedDRA releases: 2024-11 · check-in free text available
  16. 2023-03-24
    Survey response — 6 months, dose 4
    MedDRA: Bronchitis, Nasopharyngitis, Respiratory disorder — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    MedDRA releases: 2024-11
  17. 2023-03-24
    Report sent to call center — 6 months, dose 4
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  18. 2023-03-28
    Call successful
    Does not wish to fill out VAERS report

Vaccinations

DoseDateManufacturerCo-administered
12021-03-29Pfizer-BioNTech
22021-04-19Pfizer-BioNTech
32021-11-09Pfizer-BioNTech No
42022-09-23Moderna No

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 7 — days 1–6 daily, dose 2

2021-04-23

Systemic reaction (other): I am breastfeeding and my breasts have felt particularly full and sometimes I had breast discomfort in the 2-3 days following my 2nd shot.

Release 12 — 3 months, dose 4

2022-12-27

Symptoms: Colds, bronchitis, and pink eye

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDBronchitis · · ✓
SDConjunctivitis · · ✓
SDNasopharyngitis · · ✓
SDRespiratory disorder · · ✓
SROBreast feeding ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release